Skip to search formSkip to main contentSkip to account menu

MK-950

Known as: MK 950, MK950 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Timolol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1987
Highly Cited
1987
Distribution and properties of beta-adrenergic receptors in human iris-ciliary body.
beta-Adrenergic receptors from the iris-ciliary body of human eyes removed shortly after death were studied using membranes… 
1979
1979
Beta adrenergic-mediated myofibrillar disruption and enzyme efflux in an experimental myopathy related to isometric muscle activity.
1977
1977
[Lineal clinical study of a new betablocking agent, timolol maleate (MK-950), in the angina disease].
1977
1977
[Lineal clinical study of a new betablocking agent, timolol maleate (MK-950), in the angina disease].
1975
1975
A comparison of timolol and propranolol in essential hypertension.
1975
1975
Anti-Hypertensive Effect of Timolol, a New Beta-Blocking Agent (Double-Blind Study)
The anti-hypertensive effect of timolol maleate (MK-950) was evaluated in patients with mild or moderate hypertension, in a… 
Highly Cited
1974
Highly Cited
1974
A comparison of beta adrenergic blocking drugs in the treatment of hypertension
Beta adrenergic blocking drugs were found to be effective hypotensive agents in the long-term treatment of patients with… 
1972
1972
Comparison of a new beta adrenergic blocker (MK 950) and propranolol in man
The effects of oral doses of MK 950 and propranolol on heart rate in the sitting and standing positions were measured in 6… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)